Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule (CP) on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification
Acta Biochimica et Biophysica Sinica · 2025
DOI: 10.3724/abbs.2025076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2025. Verfasst von Shiyu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug Resistance, Neoplasm, Curcumin. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
- Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
- Yueqing People's Hospital, Wenzhou 325035, China.
- Department of Pharmacy, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Zitieren
APA
Wang, S., Lai, Y., Huang, H., Yuan, J., Li, S., Hui, M., Wang, P., Chen, B., Liu, Z., Qian, J., & Zhang, Q. (2025). Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule (CP) on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025076
Vancouver
Wang S, Lai Y, Huang H, Yuan J, Li S, Hui M, et al. Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule (CP) on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification. Acta Biochimica et Biophysica Sinica. 2025. doi:10.3724/abbs.2025076
BibTeX
@article{Wang2025,
author = {Wang, Shiyu and Lai, Yinshuang and Huang, Huijing and Yuan, Jing and Li, Shanxin and Hui, Min and Wang, Peipei and Chen, Bingbing and Liu, Zhiguo and Qian, Jianchang and Zhang, Qianwen},
title = {Exploring the antitumor effect of curcumin-piperlongumine hybrid molecule (CP) on EGFR-TKI-resistant non-small cell lung cancer using network pharmacological analysis and experimental verification},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2025},
doi = {10.3724/abbs.2025076}
}
EUVIMED